METHOD FOR DIAGNOSIS/PROGNOSIS OF CANCERS USING AN EPIGENETIC MARKER CONSISTING OF A SPECIFIC SINGLE CPG SITE IN TTP PROMOTER AND TREATMENT OF CANCERS BY REGULATING ITS EPIGENETIC STATUS
PURPOSE: A diagnosis for cancer using an epigenetic marker of specific single CpG site in TTP(Tristetraprolin) promoter and to treat and diagnose liver cancer. CONSTITUTION: A kit for diagnosing liver cancer contains a probe or primer pair which is able to detect methylation of cytosine residue of 3...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PARK, KYUNG CHAN YEOM, YOUNG IL SOHN, BO HWA JANG, YE JIN PARK, IN YOUNG YANG, SUK JIN YOO, HYANG SOOK LEE, JUNG JU CHOI, JONG YOUNG |
| description | PURPOSE: A diagnosis for cancer using an epigenetic marker of specific single CpG site in TTP(Tristetraprolin) promoter and to treat and diagnose liver cancer. CONSTITUTION: A kit for diagnosing liver cancer contains a probe or primer pair which is able to detect methylation of cytosine residue of 32th nucleic acid. The kit additionally contains reagent which modifies unmethylated cytosine residue. A pharmaceutical composition for preventing or treating liver cancer contains a material which suppresses methylation of cytosine residue as an active ingredient. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20110066595A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20110066595A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20110066595A3</originalsourceid><addsrcrecordid>eNqNjb0KAjEQhK-xEPUdFqzFU_HAcs3txaC3CcleYSUisRI9OJ_OpzP-FJZWMzDzzfSzR02ysSVU1kNpULMNJkydtx8HtgKFrMgHaIJhDchAzmhiEqOgRr8lD8pyKssrTwBCcKRMlfIXsiNQTicrBIZBxEHar60kELkE8YRSE8vv2XoPnnSzw_eokfD7GgSlCcOsdz5eujj66iAbVyRqM4nt7RC79niK13g_bP08n83yvCiWqyUu_ms9AdY7TLU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR DIAGNOSIS/PROGNOSIS OF CANCERS USING AN EPIGENETIC MARKER CONSISTING OF A SPECIFIC SINGLE CPG SITE IN TTP PROMOTER AND TREATMENT OF CANCERS BY REGULATING ITS EPIGENETIC STATUS</title><source>esp@cenet</source><creator>PARK, KYUNG CHAN ; YEOM, YOUNG IL ; SOHN, BO HWA ; JANG, YE JIN ; PARK, IN YOUNG ; YANG, SUK JIN ; YOO, HYANG SOOK ; LEE, JUNG JU ; CHOI, JONG YOUNG</creator><creatorcontrib>PARK, KYUNG CHAN ; YEOM, YOUNG IL ; SOHN, BO HWA ; JANG, YE JIN ; PARK, IN YOUNG ; YANG, SUK JIN ; YOO, HYANG SOOK ; LEE, JUNG JU ; CHOI, JONG YOUNG</creatorcontrib><description>PURPOSE: A diagnosis for cancer using an epigenetic marker of specific single CpG site in TTP(Tristetraprolin) promoter and to treat and diagnose liver cancer. CONSTITUTION: A kit for diagnosing liver cancer contains a probe or primer pair which is able to detect methylation of cytosine residue of 32th nucleic acid. The kit additionally contains reagent which modifies unmethylated cytosine residue. A pharmaceutical composition for preventing or treating liver cancer contains a material which suppresses methylation of cytosine residue as an active ingredient.</description><language>eng ; kor</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; COMPOSITIONS THEREOF ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; CULTURE MEDIA ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110617&DB=EPODOC&CC=KR&NR=20110066595A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110617&DB=EPODOC&CC=KR&NR=20110066595A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PARK, KYUNG CHAN</creatorcontrib><creatorcontrib>YEOM, YOUNG IL</creatorcontrib><creatorcontrib>SOHN, BO HWA</creatorcontrib><creatorcontrib>JANG, YE JIN</creatorcontrib><creatorcontrib>PARK, IN YOUNG</creatorcontrib><creatorcontrib>YANG, SUK JIN</creatorcontrib><creatorcontrib>YOO, HYANG SOOK</creatorcontrib><creatorcontrib>LEE, JUNG JU</creatorcontrib><creatorcontrib>CHOI, JONG YOUNG</creatorcontrib><title>METHOD FOR DIAGNOSIS/PROGNOSIS OF CANCERS USING AN EPIGENETIC MARKER CONSISTING OF A SPECIFIC SINGLE CPG SITE IN TTP PROMOTER AND TREATMENT OF CANCERS BY REGULATING ITS EPIGENETIC STATUS</title><description>PURPOSE: A diagnosis for cancer using an epigenetic marker of specific single CpG site in TTP(Tristetraprolin) promoter and to treat and diagnose liver cancer. CONSTITUTION: A kit for diagnosing liver cancer contains a probe or primer pair which is able to detect methylation of cytosine residue of 32th nucleic acid. The kit additionally contains reagent which modifies unmethylated cytosine residue. A pharmaceutical composition for preventing or treating liver cancer contains a material which suppresses methylation of cytosine residue as an active ingredient.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>COMPOSITIONS THEREOF</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjb0KAjEQhK-xEPUdFqzFU_HAcs3txaC3CcleYSUisRI9OJ_OpzP-FJZWMzDzzfSzR02ysSVU1kNpULMNJkydtx8HtgKFrMgHaIJhDchAzmhiEqOgRr8lD8pyKssrTwBCcKRMlfIXsiNQTicrBIZBxEHar60kELkE8YRSE8vv2XoPnnSzw_eokfD7GgSlCcOsdz5eujj66iAbVyRqM4nt7RC79niK13g_bP08n83yvCiWqyUu_ms9AdY7TLU</recordid><startdate>20110617</startdate><enddate>20110617</enddate><creator>PARK, KYUNG CHAN</creator><creator>YEOM, YOUNG IL</creator><creator>SOHN, BO HWA</creator><creator>JANG, YE JIN</creator><creator>PARK, IN YOUNG</creator><creator>YANG, SUK JIN</creator><creator>YOO, HYANG SOOK</creator><creator>LEE, JUNG JU</creator><creator>CHOI, JONG YOUNG</creator><scope>EVB</scope></search><sort><creationdate>20110617</creationdate><title>METHOD FOR DIAGNOSIS/PROGNOSIS OF CANCERS USING AN EPIGENETIC MARKER CONSISTING OF A SPECIFIC SINGLE CPG SITE IN TTP PROMOTER AND TREATMENT OF CANCERS BY REGULATING ITS EPIGENETIC STATUS</title><author>PARK, KYUNG CHAN ; YEOM, YOUNG IL ; SOHN, BO HWA ; JANG, YE JIN ; PARK, IN YOUNG ; YANG, SUK JIN ; YOO, HYANG SOOK ; LEE, JUNG JU ; CHOI, JONG YOUNG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20110066595A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2011</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>COMPOSITIONS THEREOF</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>PARK, KYUNG CHAN</creatorcontrib><creatorcontrib>YEOM, YOUNG IL</creatorcontrib><creatorcontrib>SOHN, BO HWA</creatorcontrib><creatorcontrib>JANG, YE JIN</creatorcontrib><creatorcontrib>PARK, IN YOUNG</creatorcontrib><creatorcontrib>YANG, SUK JIN</creatorcontrib><creatorcontrib>YOO, HYANG SOOK</creatorcontrib><creatorcontrib>LEE, JUNG JU</creatorcontrib><creatorcontrib>CHOI, JONG YOUNG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PARK, KYUNG CHAN</au><au>YEOM, YOUNG IL</au><au>SOHN, BO HWA</au><au>JANG, YE JIN</au><au>PARK, IN YOUNG</au><au>YANG, SUK JIN</au><au>YOO, HYANG SOOK</au><au>LEE, JUNG JU</au><au>CHOI, JONG YOUNG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR DIAGNOSIS/PROGNOSIS OF CANCERS USING AN EPIGENETIC MARKER CONSISTING OF A SPECIFIC SINGLE CPG SITE IN TTP PROMOTER AND TREATMENT OF CANCERS BY REGULATING ITS EPIGENETIC STATUS</title><date>2011-06-17</date><risdate>2011</risdate><abstract>PURPOSE: A diagnosis for cancer using an epigenetic marker of specific single CpG site in TTP(Tristetraprolin) promoter and to treat and diagnose liver cancer. CONSTITUTION: A kit for diagnosing liver cancer contains a probe or primer pair which is able to detect methylation of cytosine residue of 32th nucleic acid. The kit additionally contains reagent which modifies unmethylated cytosine residue. A pharmaceutical composition for preventing or treating liver cancer contains a material which suppresses methylation of cytosine residue as an active ingredient.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20110066595A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | METHOD FOR DIAGNOSIS/PROGNOSIS OF CANCERS USING AN EPIGENETIC MARKER CONSISTING OF A SPECIFIC SINGLE CPG SITE IN TTP PROMOTER AND TREATMENT OF CANCERS BY REGULATING ITS EPIGENETIC STATUS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A27%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PARK,%20KYUNG%20CHAN&rft.date=2011-06-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20110066595A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |